|
|
|
|
LEADER |
00000cam a2200000Mu 4500 |
001 |
EBOOKCENTRAL_ocn828299310 |
003 |
OCoLC |
005 |
20240329122006.0 |
006 |
m o d |
007 |
cr |n||||||||| |
008 |
130223s2013 nyu o 000 0 eng d |
040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d OCLCQ
|d OCLCO
|d UKDOC
|d OCLCQ
|d MERUC
|d ZCU
|d ICG
|d OCLCF
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d DKC
|d OCLCQ
|d HS0
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCL
|
020 |
|
|
|a 9781118556733
|
020 |
|
|
|a 1118556739
|
029 |
1 |
|
|a AU@
|b 000055873688
|
029 |
1 |
|
|a DEBBG
|b BV044172887
|
035 |
|
|
|a (OCoLC)828299310
|
050 |
|
4 |
|a RC537
|
060 |
1 |
0 |
|a WM 171.5
|
082 |
0 |
4 |
|a 616.85/2706
|a 616.8527
|a 616.852706
|
049 |
|
|
|a UAMI
|
100 |
1 |
|
|a Kasper, S.
|q (Siegfried)
|1 https://id.oclc.org/worldcat/entity/E39PBJmHHtKh3cF94wTtV6Gfv3
|
245 |
1 |
0 |
|a Treatment-Resistant Depression.
|
250 |
|
|
|a 2nd ed.
|
260 |
|
|
|a New York :
|b Wiley,
|c 2013.
|
300 |
|
|
|a 1 online resource (229 pages)
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
505 |
0 |
|
|a Treatment-resistant Depression; Copyright; Contents; List of Contributors; Foreword; Chapter 1 Definitions and Predictors of Treatment resistant Depression; Summary; Introduction; Definition of TRD: historical perspective; TRD staging models; Thase and Rush model (1997); European staging model (1999); Massachusetts general hospital staging model (2003); Maudsley staging model (2009); Definition of TRD in clinical trials; Clinical characteristics and predictors of TRD; Conclusions; References; Chapter 2 Treatment-resistant Depression: A Separate Disorder -- A New Approach; Summary; Introduction.
|
505 |
8 |
|
|a Historical backgroundCurrent TRD concepts and their limitations; Towards a new definition and nosology; Towards a new terminology: malignant, pernicious or virulent depression; References; Chapter 3 Genetics of Treatment-resistant Depression; Summary; Introduction; Genetic polymorphisms and antidepressant efficacy; Antidepressant pharmacodynamics; Antidepressant pharmacokinetics; Conclusions; References; Chapter 4 Is There a Role for Switching Antidepressants in Treatment-resistant Depression?; Summary; Introduction; Raising the dose; Switching antidepressant pharmacological class.
|
505 |
8 |
|
|a Serotonin norepinephrine reuptake inhibitorsSelective serotonin reuptake inhibitors; Guidelines on second-step treatment of nonresponders; Does switching class of antidepressant improve response?; Conclusions; References; Chapter 5 The Role of Atypical Antipsychotics in Inadequate-response and Treatment-resistant Depression; Summary; Introduction; Epidemiology: prescription data; Efficacy of SGAs in TRD; Side effects; Conclusions; References; Chapter 6 Lithium, Thyroid Hormones and Further Augmentation Strategies in Treatment-resistant Depression; Summary; Introduction; Augmentation studies.
|
505 |
8 |
|
|a LithiumThyroid hormones; Anticonvulsants; Dopamine agonists; Psychostimulants; Buspirone; S-Adenosyl methionine; Omega-3 polyunsaturated fatty acids; Combined treatment with antidepressants from the beginning: acceleration studies; Lithium; Triiodothyronine; Pindolol; Polyunsaturated fatty acids; Conclusions; References; Chapter 7 The Role of Nonpharmacological Interventions in Treatment-resistant Depression; Summary; Introduction; Electroconvulsive therapy; Indications, contraindications and risks; Mechanism of action; Procedure and stimulation parameters; Side effects; Outlook.
|
505 |
8 |
|
|a Repetitive transcranial magnetic stimulationIndications, contraindications and risk; Mechanism of action; Procedure and stimulation parameters; Side effects; Outlook; Vagus nerve stimulation; Indications, contraindications and risk; Mechanism of action; Procedure and stimulation parameters; Side effects; Outlook; Deep-brain stimulation; Indications, contraindications and risk; Mechanism of action and targets; Procedure and stimulation parameters; Side effects; Outlook; Ethical considerations; Magnetic seizure therapy; Indications, contraindications and risk; Mechanism of action.
|
500 |
|
|
|a Procedure and stimulation parameters.
|
520 |
|
|
|a The first book devoted to a challenging disorder that affects millions of people around the world. Essential reading for all psychiatrists who manage these patients.
|
588 |
0 |
|
|a Print version record.
|
590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
650 |
|
0 |
|a Depression, Mental
|x Treatment.
|
650 |
|
0 |
|a Drug resistance.
|
650 |
|
2 |
|a Drug Resistance
|
650 |
|
6 |
|a Dépression
|x Traitement.
|
650 |
|
6 |
|a Résistance aux médicaments.
|
650 |
|
7 |
|a Depression, Mental
|x Treatment
|2 fast
|
650 |
|
7 |
|a Drug resistance
|2 fast
|
700 |
1 |
|
|a Montgomery, Stuart A.
|
776 |
0 |
8 |
|i Print version:
|a Kasper, Siegfried.
|t Treatment-Resistant Depression.
|d New York : Wiley, ©2013
|z 9781119952909
|
856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=1124632
|z Texto completo
|
938 |
|
|
|a 123Library
|b 123L
|n 64431
|
938 |
|
|
|a EBL - Ebook Library
|b EBLB
|n EBL1124632
|
994 |
|
|
|a 92
|b IZTAP
|